Characterization of B16 melanoma-specific cytotoxic T lymphocytes

Abstract

A B16 melanoma-specific CD8+ T cell line (AB1) was established from the spleen cells of C57BL/6 mice cured of B16 melanoma with interleukin (IL)-12 treatment. The AB1 line exclusively used T cell receptor Vβ11. The AB1 cells exhibited a cytolytic activity against both syngeneic B16 melanoma and allogeneic P815 mastocytoma, whereas a cold inhibition assay… (More)
DOI: 10.1007/s002620050521

Topics

5 Figures and Tables

Cite this paper

@article{Harada1998CharacterizationOB, title={Characterization of B16 melanoma-specific cytotoxic T lymphocytes}, author={Mamoru Harada and Koji Tamada and Koichiro Abe and Tieli Li and Yasuhiro Onoe and Hitoshi Tada and Katsunori Tatsugami and Takashi Ando and Genki Kimura and Kikuo Nomoto}, journal={Cancer Immunology, Immunotherapy}, year={1998}, volume={47}, pages={198-204} }